Atezolizumab for adjuvant treatment of high-risk locally advanced squamous cell head and neck cancer [ID4052]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Xevinapant with platinum-based chemotherapy and radiotherapy for untreated locally advanced squamous cell head and neck cancer [ID6199]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer [ID6406]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
High linear energy transfer radiation for carbon ion beam therapyStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Pembrolizumab for neoadjuvant and with radiotherapy for adjuvant treatment of newly diagnosed resectable locally advanced squamous cell head and neck cancer TS ID 12068Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC